Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAS
Basis Energy Services, Inc.
BAS
|
+$159M |
| 2 |
Freeport-McMoran
FCX
|
+$137M |
| 3 |
Walt Disney
DIS
|
+$129M |
| 4 |
Alcoa
AA
|
+$98.7M |
| 5 |
CMA
Comerica
CMA
|
+$87.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$187M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$177M |
| 3 |
ANDV
Andeavor
ANDV
|
+$166M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$160M |
| 5 |
Union Pacific
UNP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.65% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 7.79% |
| 5 | Materials | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
FNB Corp
FNB
$6.6B
| $23.9M | 0.13% |
1,489,585
+102,212
| +7% | +$1.46M |
|
227
PUT
Biogen
BIIB
$32B
| $23.5M | 0.13% |
+90,000
| New | +$26.7M |
|
228
Healthpeak Properties
DOC
$14.8B
| $23.4M | 0.13% |
+788,338
| New | +$24M |
|
|
WPZ
229
DELISTED
Williams Partners L.P.
WPZ
| $23.4M | 0.13% |
+615,027
| New | +$22.1M |
|
230
East-West Bancorp
EWBC
$17.8B
| $23.2M | 0.12% |
456,014
+42,058
| +10% | +$1.87M |
|
231
Kraft Heinz
KHC
$30.3B
| $23.2M | 0.12% |
+265,309
| New | +$22.7M |
|
232
PUT
Apple
AAPL
$4.51T
| $23.2M | 0.12% |
+800,000
| New | +$22.7M |
|
233
Kinder Morgan
KMI
$69B
| $23M | 0.12% |
1,112,074
-1,229,382
| -53% | -$26M |
|
234
McKesson
MCK
$100B
| $23M | 0.12% |
163,774
+148,584
| +978% | +$21.9M |
|
235
Thermo Fisher Scientific
TMO
$233B
| $22.9M | 0.12% |
+162,374
| New | +$23.9M |
|
|
SWFT
236
CALL
DELISTED
Swift Transportation Company
SWFT
| $22.9M | 0.12% |
+940,000
| New | +$21.9M |
|
|
WMGI
237
DELISTED
Wright Medical Group Inc
WMGI
| $22.9M | 0.12% |
995,908
-117,764
| -11% | -$2.74M |
|
238
Zebra Technologies
ZBRA
$17.4B
| $22.7M | 0.12% |
265,140
-222,669
| -46% | -$16.5M |
|
239
Regency Centers
REG
$13.9B
| $22.7M | 0.12% |
329,354
+130,588
| +66% | +$9.09M |
|
240
Canadian Natural Resources
CNQ
$106B
| $22.7M | 0.12% |
1,452,856
-1,229,056
| -46% | -$19.5M |
|
|
MSGN
241
DELISTED
MSG Networks Inc.
MSGN
| $22.5M | 0.12% |
1,045,888
-42,223
| -4% | -$841K |
|
|
X
242
DELISTED
US Steel
X
| $22.5M | 0.12% |
+680,941
| New | +$18.2M |
|
243
OGE Energy
OGE
$9.42B
| $22.4M | 0.12% |
670,702
+88,421
| +15% | +$2.79M |
|
244
Cullen/Frost Bankers
CFR
$10.2B
| $22.4M | 0.12% |
254,120
+22,518
| +10% | +$1.81M |
|
245
Nucor
NUE
$55.3B
| $22.3M | 0.12% |
374,365
+370,265
| +9,031% | +$20.7M |
|
|
VMW
246
DELISTED
VMware, Inc
VMW
| $22.2M | 0.12% |
281,794
-1,022,856
| -78% | -$79.4M |
|
247
Clorox
CLX
$12.9B
| $22.1M | 0.12% |
+184,514
| New | +$21.8M |
|
|
MPT
248
Medical Properties Trust
MPT
$2.46B
| $22M | 0.12% |
1,789,004
+754,424
| +73% | +$9.76M |
|
249
Paychex
PAYX
$44.3B
| $21.7M | 0.12% |
+356,793
| New | +$20.6M |
|
250
Halliburton
HAL
$29.4B
| $21.7M | 0.12% |
+400,700
| New | +$20M |
|
Similar funds
Dmitry Balyasny's Q4 2016 Portfolio in Review
As of Q4 2016, Dmitry Balyasny held 1,603 positions worth $18.6B, up 7.6% from $17.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Dmitry Balyasny's Q4 2016 filing shows 632 new, 338 increased, 353 reduced and 276 closed positions. Its largest new stake was Basis Energy Services, Inc.: 586,398 shares worth $20.7M. The largest sale was Eli Lilly, an estimated $187M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q4 2016 buy was Basis Energy Services, Inc.: 586,398 shares worth $20.7M.
- Dmitry Balyasny added most to Alcoa in Q4 2016, an estimated $98.7M increase.
- Dmitry Balyasny's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $187M.
- Dmitry Balyasny fully exited Canadian Pacific Kansas City in Q4 2016, selling an estimated $160M.
- Dmitry Balyasny's ten largest holdings make up 8.7% of its $18.6B portfolio in Q4 2016.
- Dmitry Balyasny opened 632 new positions and closed 276 in Q4 2016.
- Dmitry Balyasny's portfolio value rose 7.6% quarter-over-quarter to $18.6B.
Based on Balyasny Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.